I'm not the right kind of doctor (Ph.D. in Mathematics) to know what's in that pipeline. Our Oncologists would be the best source of that knowledge. Or maybe explore AstraZeneca's website.

I tried searching ClinicalTrials.gov for "non-small cell adenocarcinoma" with the other terms of "EGFR mutation" to see a list of the current clinical trials with their statuses. It's interesting reading with a lot of big words, but I don't know that any pharmacies are using this information to develop new treatments.